Ibrucent 140 Mg| Ibrutinib Price| zanubrutinib vs ibrutinib

$ 190.00

Ibrucent 140 mg is used for the treatment of Mantle Cell Lymphoma (MCL), It is prescribed for those who have already had at least one other treatment. It is also used for individuals with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), including those with a specific genetic change known as 17p deletion.